The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs
Recenti Progressi in Medicina · 2023
DOI: 10.1701/4088.40818 ↗Kurz gefasst
Leserbrief in der Zeitschrift Recenti Progressi in Medicina, 2023. Verfasst von Jacopo Giuliani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Az. Ulss 9 Scaligera, Legnago (Verona), Italy. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colorectal Neoplasms, Antineoplastic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Az. Ulss 9 Scaligera, Legnago (Verona), Italy.
- Department of Diagnostic Imaging, Az. Ulss 9 Scaligera, Legnago (Verona), Italy.
- Istituto tecnico Bachelet, Ferrara, Italy.
Zitieren
APA
Giuliani, J., Mantoan, B., Candela, M. V., Napoli, G., Muraro, M., Mangiola, D., & Mandara, M. (2023). The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs. Recenti Progressi in Medicina. https://doi.org/10.1701/4088.40818
Vancouver
Giuliani J, Mantoan B, Candela MV, Napoli G, Muraro M, Mangiola D, et al. The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs. Recenti Progressi in Medicina. 2023. doi:10.1701/4088.40818
BibTeX
@article{Giuliani2023,
author = {Giuliani, Jacopo and Mantoan, Beatrice and Candela, Maria Viviana and Napoli, Giuseppe and Muraro, Marco and Mangiola, Daniela and Mandara, Marta},
title = {The screening with the liquid biopsy for the rechallenge with anti-epidermal growth factor receptor antibodies in metastatic colorectal cancer A perspective based on pharmacological costs},
journal = {Recenti Progressi in Medicina},
year = {2023},
doi = {10.1701/4088.40818}
}
EUVIMED